Cardiovascular risk markers are increased in HIV-infected children with lipodystrophy syndrome.
María
M
Guzmán-Fulgencio
Dariela
D
Micheloud
Raquel
R
Lorente
Jose María
JM
Bellón
María Isabel de José
MI
Gomez
María Dolores
MD
Gurbindo
Juan Antonio
JA
León
María Ángeles
MÁ
Muñoz-Fernández
Salvador
S
Resino
D000293:Adolescent; D019380:Anti-HIV Agents / Q000009:adverse effects*; D023241:Antiretroviral Therapy, Highly Active / Q000379:methods*; D015415:Biomarkers / Q000097:blood*; D002318:Cardiovascular Diseases / Q000175:diagnosis*; D002648:Child; D002675:Child, Preschool; D005260:Female; D039682:HIV-Associated Lipodystrophy Syndrome / Q000139:chemically induced* / Q000150:complications*; D006801:Humans; D008297:Male; D018570:Risk Assessment
D019380:Anti-HIV Agents; D015415:Biomarkers